Jasper Therapeutics, Inc.

JSPR · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
126
SEC Filings

Business Summary

PART I Overview We are a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma and we continue to consider additional indications in mast cell driven diseases for potential future development. We have also historically explored development programs in diseases where targeting diseased hemopoietic stem cells can provide benefits, such as stem cell trans...

Next Earnings

Q2 FY2026 — expected 2026-09-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionJSPRdiscussed_in_filing Cybersecurity
topic_mentionJSPRdiscussed_in_filing Trusted Computing
topic_mentionJSPRdiscussed_in_filing Blockchain & Crypto
topic_mentionJSPRdiscussed_in_filing Supply Chain
topic_mentionJSPRdiscussed_in_filing Regulation
topic_mentionJSPRdiscussed_in_filing Healthcare & Bio
topic_mentionJSPRdiscussed_in_filing Cybersecurity
topic_mentionJSPRdiscussed_in_filing Trusted Computing
topic_mentionJSPRdiscussed_in_filing Blockchain & Crypto
topic_mentionJSPRdiscussed_in_filing Supply Chain
topic_mentionJSPRdiscussed_in_filing Regulation
topic_mentionJSPRdiscussed_in_filing Healthcare & Bio
topic_mentionJSPRdiscussed_in_filing Cybersecurity
topic_mentionJSPRdiscussed_in_filing Trusted Computing
topic_mentionJSPRdiscussed_in_filing Blockchain & Crypto
topic_mentionJSPRdiscussed_in_filing Supply Chain
topic_mentionJSPRdiscussed_in_filing Regulation
topic_mentionJSPRdiscussed_in_filing Healthcare & Bio
topic_mentionJSPRdiscussed_in_filing Cybersecurity
topic_mentionJSPRdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001213900-26-036426EDGAR99K words
2025-02-282024-12-310001213900-25-018384EDGAR
2024-03-052023-12-310001213900-24-020114EDGAR
2023-03-082022-12-310001213900-23-018542EDGAR
2022-03-182021-12-310001213900-22-013592EDGAR
2021-03-302020-12-310001213900-21-018735EDGAR
2020-03-262019-12-310001213900-20-007505EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001213900-25-107884EDGAR39K words
2025-08-132025-06-300001213900-25-075635EDGAR
2025-05-122025-03-310001213900-25-042011EDGAR
2024-11-072024-09-300001213900-24-095173EDGAR
2024-08-132024-06-300001213900-24-067897EDGAR
2024-05-142024-03-310001213900-24-042805EDGAR
2023-11-092023-09-300001213900-23-084970EDGAR
2023-08-112023-06-300001213900-23-066234EDGAR
2023-05-122023-03-310001213900-23-039021EDGAR
2022-11-102022-09-300001213900-22-071165EDGAR
2022-08-122022-06-300001213900-22-047382EDGAR
2022-05-122022-03-310001213900-22-025945EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001213900-26-036448EDGAR3K words
2026-01-080001213900-26-002329EDGAR
2026-01-070001213900-26-002185EDGAR
2025-12-020001213900-25-116943EDGAR
2025-11-100001213900-25-107874EDGAR
2025-09-190001213900-25-089584EDGAR
2025-08-130001213900-25-075678EDGAR
2025-07-090001213900-25-062194EDGAR
2025-07-070001213900-25-061632EDGAR
2025-07-030001213900-25-061471EDGAR

126 total filings indexed. 97 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001788028
TickerJSPR
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 2e3003e53b3c346384818db7ff50b26b5e889fb32d54932813165654403fc195
parent: e3bc4ccfe3a8684bac032c799529000d1d963b77b166ecdf510860c3af658830
content hash: 7012f3d79451fd683fe843b8f062dbfb5a7a663100ff87b691c6f6113ade23bb
signed: 2026-04-13T04:45:50.417Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf